Paradeep Phosphates Board Approves Q3 FY26 Results & Key Management Appointments
Paradeep Phosphates reported unaudited standalone and consolidated results for the nine months ended December 31, 2025, with profit before tax at ₹1,126.27 crore and ₹1,125.78 crore, respectively. The Board re-appointed N Suresh Krishnan as MD and appointed K K Rajeev Nambiar as Joint MD, both for three-year terms.
The financial results provide an update on the company's performance, and the management appointments are significant for future strategy and operations.
The company reported its financial results and approved key management appointments, indicating stability and continued leadership.
Paradeep Phosphates Limited announced the outcome of its Board of Directors meeting held on February 02, 2026. The Board considered and approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, as recommended by the Audit Committee.
The meeting also saw the approval for the re-appointment of Mr. N Suresh Krishnan as Managing Director and Key Managerial Personnel for a period of three years, effective February 16, 2026, subject to member approval. Additionally, Mr. K K Rajeev Nambiar was appointed as Joint Managing Director and Key Managerial Personnel for a period of three years, effective April 01, 2026, also subject to member approval.
The financial results for the nine months ended December 31, 2025, showed total income of ₹17,231.11 crore for standalone and ₹17,231.11 crore for consolidated. Profit before tax for the nine months stood at ₹1,126.27 crore (standalone) and ₹1,125.78 crore (consolidated). For the quarter ended December 31, 2025, profit before tax was ₹233.37 crore (standalone) and ₹233.38 crore (consolidated).
The company also noted an exceptional item of ₹41.30 crore related to the impact of new Labour Codes. The financial statements reflect restatements due to the Composite Scheme of Arrangement for the amalgamation of Mangalore Chemicals & Fertilizers Limited (MCFL) with the company, with an appointed date of April 01, 2024. The acquisition of a part of the business of Zuari Agro Chemicals Limited has also been provisionally accounted for.
What to do with a filing like this
Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.